-transparent.png){kind=logo}
Haemoperfusion through Amberlite XAD-4 was used in a female patient who took with suicidal intention 29 tablets of Syntophylline. During 5 hours of haemoperfusion the theophylline plasma concentration declined significantly to the lower limit of the therapeutic range. Early application of haemoperfusion, using Amberlite XAD-4, led to rapid regression of symptoms of acute intoxication and recovery of the patient.
Related Publications
M Mydlík, and
K Derzsiová, and
P Smolko, and
V Petríková, and
T Vzenteková
October 1981,
La Revue de medecine interne,
M Mydlík, and
K Derzsiová, and
P Smolko, and
V Petríková, and
T Vzenteková
November 1982,
Journal of toxicology. Clinical toxicology,
M Mydlík, and
K Derzsiová, and
P Smolko, and
V Petríková, and
T Vzenteková
October 1980,
Clinical toxicology,
M Mydlík, and
K Derzsiová, and
P Smolko, and
V Petríková, and
T Vzenteková
May 1979,
Artificial organs,
M Mydlík, and
K Derzsiová, and
P Smolko, and
V Petríková, and
T Vzenteková
January 1982,
Transactions - American Society for Artificial Internal Organs,
M Mydlík, and
K Derzsiová, and
P Smolko, and
V Petríková, and
T Vzenteková
August 1991,
Ugeskrift for laeger,
M Mydlík, and
K Derzsiová, and
P Smolko, and
V Petríková, and
T Vzenteková
March 1982,
Lakartidningen,
M Mydlík, and
K Derzsiová, and
P Smolko, and
V Petríková, and
T Vzenteková
February 1979,
Artificial organs,
M Mydlík, and
K Derzsiová, and
P Smolko, and
V Petríková, and
T Vzenteková
September 1987,
Harefuah,
M Mydlík, and
K Derzsiová, and
P Smolko, and
V Petríková, and
T Vzenteková
January 1980,
Acta medica Scandinavica,
